Getinge targets growth in expanding respiratory technology market

Getinge is attracting investor attention due to the projected long-term growth in the respiratory and intensive care medicine markets. A market report estimates that the global volume for respiratory devices will reach $59.15 billion by 2035.

Getinge currently holds approximately a 6 percent market share in this segment. The company’s position is supported by a portfolio that includes mechanical ventilators, critical care monitoring solutions, and clinical respiratory equipment integrated into hospital workflows.

While the expanding market offers significant revenue potential, investors are monitoring whether the company can stabilize or expand its market share amidst challenges such as regulatory requirements and cost pressures within hospital operations.